Two Massive Deals, One Regeneron Disaster, and Oil Near $110

Stocks retreated today as bond yields stayed elevated, and oil held near $110. Two massive M&A deals dominated the tape: Publicis agreed to buy LiveRamp for $2.5 billion, and NextEra announced a $67 billion deal to acquire Dominion Energy.

Today’s edition has every name that moved and what it means heading into a week where Kevin Warsh officially becomes Fed chair.

Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME."

But here's the thing - most investors will be locked out until AFTER it goes public.

Not you.

I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now.

Click Here for the FREE "SpaceX" Ticker

A major holder sold nearly $496 million worth of stock in a cloud software name after a 410% one-year run, while another asset management stock saw more than $320 million in insider-linked selling near its 52-week high.

This may only look like two big sales to you, but Elite Trade Club Insider readers will see where major holders are using strong markets to cash out after the easy money has already been made.

A subscription gets you:

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

Tech stocks led markets lower Monday as bond yields stayed elevated near their highest in over a year and oil climbed back toward $110, with the Trump-Xi summit’s tangible outputs limited to a $17 billion U.S. agricultural goods commitment from China rather than the chip or trade deals equity markets had been pricing in.

Regeneron dragged the Nasdaq lower after its experimental melanoma drug fianlimab failed to outperform Keytruda in a pivotal trial, a miss that erased roughly 11% of the company’s market value in a single session. The M&A market was the session’s counterweight: Publicis Groupe agreed to acquire LiveRamp for $2.5 billion in cash at a 30% premium, and NextEra Energy announced a $67 billion deal to acquire Dominion Energy in one of the year’s largest utility transactions.

NextEra Energy Inc (NYSE: NEE) just agreed to buy Dominion Energy for $66.8 billion, creating the world's largest regulated electric utility.

Dominion serves 3.6 million customers across Virginia and the Carolinas.

More importantly, it controls nearly 51 gigawatts of contracted data center capacity, including Northern Virginia's "Data Center Alley," the biggest concentration of data centers on earth.

NextEra did not buy a utility. It bought the power grid underneath the AI revolution.

Data Center Alley Is the Prize

Every major tech company runs data centers in Northern Virginia. Google, Amazon, Microsoft, Meta, CoreWeave, Equinix. They all depend on Dominion for electricity. That customer list now belongs to NextEra.

You control the power supply to the companies building AI infrastructure, and the leverage is enormous. They cannot run servers without electricity, and NextEra now decides how much of it they get.

A Wave of Deals and NextEra Just Made the Biggest One

Multiple utility mergers have closed this year. NextEra's deal dwarfs them all. The combined company serves over 15 million people across some of the most economically active regions in America.

You watch the energy industry consolidate around AI-driven demand, and one company keeps landing in the center of it.

NextEra was already the largest clean energy developer on earth. Now it owns the grid that powers the machines building the future.

Regeneron Pharmaceuticals (NASDAQ: REGN) late-stage melanoma trial just delivered results no one wanted to see. The treatment showed no meaningful improvement for patients with advanced melanoma.

This was supposed to be the trial that established Regeneron as a serious challenger in one of the most competitive cancer markets on earth.

Instead, it became the reason the company had to announce a brand new strategy on the same day.

The Pivot Came Fast

Hours after the trial failure, Regeneron announced a major new partnership with Parabilis Medicines, valued at up to $2.2 billion. The deal combines Regeneron's antibody technology with Parabilis' peptide platform.

That speed tells the full story. Regeneron had this partnership in place before the results were released.

When a company announces a multibillion-dollar collaboration the same day its biggest trial fails, your read should be that leadership knew this outcome was possible and prepared accordingly.

The Oncology Dream Is Not Dead

One failed trial does not end a company's cancer ambitions. But it does reset the timeline and change the approach.

Regeneron is pivoting from going head-to-head with established treatments to building something new through partnerships and platform technology.

You expected Regeneron to challenge the cancer drug giants this year. That fight now starts later and looks very different from what anyone planned.

Right now, one company is quietly powering critical operations across the U.S. military. That company is SpaceX.

But the real story may be what happens next.

There's growing speculation that Elon Musk could bring SpaceX public in the future.

Events like this don't happen often — and when they do, early access matters. Some believe this could be one of the biggest investment opportunities of the decade.

Learn how to position ahead of it

Ford Motor Company (NYSE: F) just made one of its boldest strategic moves in years by launching Ford Energy, a new business focused on battery storage systems for utilities, commercial operators, and data centers.

The company is partnering with EDF, one of the world's largest energy companies, to deliver large-scale power storage systems starting later this decade.

The goal here goes way beyond selling another lineup of vehicles. It's a strategic move to sit right at the heart of the infrastructure powering future industries.

Cars Are No Longer the Full Story

Ford is stepping into energy storage at a time when power demand is exploding from AI infrastructure, industrial expansion, and electrification. Large battery systems are becoming essential to how grids and facilities operate.

What catches you here is the scale of the ambition. Ford is no longer attaching itself only to transportation; it is entering the business of energy stability itself.

A Different Kind of Industrial Company Is Emerging

Battery storage opens new doors for Ford outside consumer vehicles. Utilities, data centers, and industrial operators are now becoming potential long-term customers.

That's where your reading on the company starts to change. Ford is positioning itself as an industrial infrastructure player rather than remaining tied solely to car sales.

Pressure Also Creates Opportunity

Traditional automakers have spent years dealing with thinner margins, expensive EV transitions, and fierce global competition.

Expanding into infrastructure creates another growth lane with long-term demand.

The larger direction is becoming impossible to ignore. Eventually, you start seeing Ford less as a traditional automaker and more as a company building itself around the systems powering future industries.

LiveRamp [RAMP] $37.74 (+27.24%)

Publicis Groupe announced it is acquiring LiveRamp for $38.50 per share in an all-cash deal valuing the company at $2.167 billion, a 30% premium to the prior close.

LiveRamp connects brand first-party data to media networks, and Publicis is essentially buying the data infrastructure layer its entire advertising business depends on. The deal is expected to close in the second half of 2026 and both boards have approved.

T1 Energy [TE] $7.02 (+23.81%)

T1 Energy reported Q1 revenue of $177.6 million ahead of expectations and narrowed its net loss to $0.08 per share, beating estimates. Hedge fund Situational Awareness LP simultaneously disclosed a new 10 million share stake via a 13F filing, and institutional ownership hit an all-time high.

Revenue growing, losses shrinking, and a new institutional believer announcing on the same Monday morning is a powerful combination for a stock with this kind of momentum already behind it.

Genius Sports [GENI] $5.18 (+22.17%)

Genius Sports reported Q1 revenue up 31% year-over-year and adjusted EBITDA up 21%, completed the Legend acquisition, and raised 2026 EBITDA margin guidance to 28% on the back of immediately accretive synergies.

A new AI and technology partnership with Liga MX confirmed the company’s global sports data expansion is real and accelerating. At a $1.38 billion Buy-rated market cap, this is an earnings beat backed by a concrete margin improvement story.

Edesa Biotech [EDSA] $9.00 (-31.03%)

Edesa is reversing its recent multi-week momentum run with no new negative catalyst on Monday. The $86M Strong Buy-rated company had run aggressively on biotech sector tailwinds and is now giving some of that back as the risk-off tone from elevated yields hits speculative clinical-stage names first.

The paridiprubart pipeline is unchanged and the reversal is momentum, not fundamentals.

Design Therapeutics [DSGN] $10.70 (-25.54%)

Design Therapeutics reported positive biomarker data from its Phase 1/2 RESTORE-FA trial for Friedreich ataxia, showing improvements in frataxin protein levels, but the data fell short of demonstrating a clear clinical efficacy signal on neurological function that investors were positioned for.

Positive biomarkers without clean functional endpoints are a familiar biotech heartbreak, and the market sold the miss even though the underlying biology story remains intact.

Trio-Tech International [TRT] $15.32 (-23.59%)

Trio-Tech provides semiconductor testing and burn-in services in Southeast Asia and has run hard on the chip sector rally over the past month. Monday’s reversal is a combination of profit-taking after the chip sector’s steep correction from Friday’s post-China summit disappointment and no specific company news to anchor buyers.

The $150M no-rating stock is a pure momentum vehicle for the chip cycle thesis and trades accordingly.

Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with.

For now, you can try this AI yourself, completely free of charge – no email, no credit card.

Click here to learn more.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.